Postbooster Antibodies from Humans as Source of Diphtheria Antitoxin.
Diphtheria antitoxin for therapeutic use is in limited supply. A potential source might be affinity-purified antibodies originally derived from plasma of adults who received a booster dose of a vaccine containing diphtheria toxoid. These antibodies might be useful for treating even severe cases of diphtheria.
Jesús F
JF
Bermejo-Martin
Ana
A
Avila-Alonso
Milagros
M
González-Rivera
Eduardo
E
Tamayo
Jose María
JM
Eiros
Raquel
R
Almansa
D000907:Antibodies, Bacterial / Q000276:immunology*; D003353:Corynebacterium diphtheriae; D004165:Diphtheria / Q000517:prevention & control*; D004166:Diphtheria Antitoxin / Q000276:immunology*; D004168:Diphtheria Toxoid / Q000276:immunology*; D006801:Humans; D007117:Immunization, Secondary
D000907:Antibodies, Bacterial; D004166:Diphtheria Antitoxin; D004168:Diphtheria Toxoid
Corynebacterium diphtheriae; antibodies; antitoxin; bacteria; booster; diphtheria; vaccination